EngelNovitt, PLLC ("EngelNovitt") is an internationally-recognized boutique law firm with a global biopharmaceuticals and medical device client base spanning Europe, the United States, and the Pacific Rim. Recognized as a leader in addressing legal/regulatory and compliance issue impacting FDA-regulated industries, EngelNovitt develops and implements innovative and forward-thinking science-based solutions to anticipate and resolve complex scientific, science policy, legal/regulatory, legislative, life-cycle management, public policy, and business issues affecting innovative industries in the firm's core practice areas relating to drugs, biologics, medical devices, genomics, research tools, and food products. [More]
EngelNovitt is managed by John Engel, who brings over 25 years of experience working with cutting-edge biopharmaceuticals, device, clinical research and drug development, and life sciences industries. [More]
2401 Pennsylvania Avenue, N.W., Suite 310
Washington, D.C. 20037
Telephone +1.202.207.3300 - Facsimile +1.202.207.3318 - email: < engelnovitt AT engelnovitt.com >